androisoxazole androisoxazole androisoxazole (brand names androxan, neo-ponden, neo-pondus), also known as 17α-methyl-5α-androstanoisoxazol-17β-ol, is an orally active anabolic-androgenic steroid (aas) and a 17α-alkylated derivative of dihydrotestosterone (dht) that is marketed in spain and italy. it is closely related to stanozolol, differing only in having an isoxazole instead of pyrazole ring fused to the a ring, and is also related to furazabol, prostanozol, and danazol. androisoxazoleclinical datatrade namesandroxan, neo-ponden, neo-pondusother names17α-methyl-5α-androstanoisoxazol-17β-olroutes ofadministrationby mouthdrug classandrogen; anabolic steroididentifiers iupac name 2,3,3a,3b,4,5,5a,6,10,10a,10b,11,12,12a-tetradecahydro-1,10a,12a-trimethyl-1h-cyclopentaphenanthroisoxazol-1-ol cas number360-66-7 ypubchem cid9676chemspider9295 yunii6wrg30p3cgcomptox dashboard (epa)dtxsid40957423 chemical and physical dataformulac21h31no2molar mass329.484 g·mol−13d model (jsmol)interactive image smiles o5(c)cc43(2(cc1c(noc1)c2cc3)c)cc45c inchi inchi=1s/c21h31no2/c1-19-11-13-12-24-22-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)23/h12,14-17,23h,4-11h2,1-3h3/t14-,15+,16-,17-,19-,20-,21-/m0/s1 ykey:nsytunfhwymmhu-iyrcevngsa-n y (verify)